Cargando…
Insulin-like growth factor-1 stimulates regulatory T cells and suppresses autoimmune disease
The recent precipitous rise in autoimmune diseases is placing an increasing clinical and economic burden on health systems worldwide. Current therapies are only moderately efficacious, often coupled with adverse side effects. Here, we show that recombinant human insulin-like growth factor-1 (rhIGF-1...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237469/ https://www.ncbi.nlm.nih.gov/pubmed/25339185 http://dx.doi.org/10.15252/emmm.201303376 |